April Shanghai CMTF Conference preview: Clinical Translation and Industrial Innovation Driven by iPSC and Exosomes
（Zhenghe · CMTF） The 26th Shanghai International Medical Tourism Fair
Co-located with:
The 16th Cell Biology Industry, Cell Therapy & Regenerative Medicine Conference
The 9th International Functional Medicine & Longevity Technology Innovation Conference
Location: Shanghai Exhibition Center Time: April 23 - 25
（If you want to receive more conference agenda and details, please contact organizer: camelliachenchen@gmail.com.）
Amid global demographic shifts and escalating health demands, the medical industry is transitioning from traditional "disease treatment" to "full life-cycle health management." Groundbreaking advancements in frontier fields such as assisted reproduction, oncology, cell therapy, regenerative medicine, and functional medicine are accelerating the restructuring of global medical service models, technical pathways, and industry landscapes. Future healthcare will be more technology-driven and cross-collaborative, forming a comprehensive service system encompassing prevention, diagnosis, treatment, and health management. Zhenghe · CMTF is not only a showcase for cutting-edge international medical technologies but also a central hub for the deep integration of cross-border healthcare, functional medicine, and cell biology. It serves as an industry bellwether for gaining market insights and connecting with global resources.
On-site showcase of global specialty medical care, gathering multi-dimensional health products. Whether you are looking to expand new business ventures or take charge of proactive health, the event will open the door to resource collaboration and networking.
300+ International hospitals and enterprises shining on display
200+ Lectures sparking ideological exchange across 4 major forum areas
25,000+ Professional visitors and high-net-worth individuals gathering together
Panoramic Scan of Exhibition Scope:
Medical Tourism Sector: Global premium medical resources landing here! Covering multi-national assisted reproduction, precision physical examinations, oncology, critical care, cell therapy, stem cells & regenerative medicine, medical aesthetics & plastic surgery, anti-aging, imported pharmaceuticals, and health & wellness tourism.
Functional Medicine & Longevity Technology Sector: Encompassing products and services for chronic disease management, delayed food allergy testing, microbiota transplantation, intestinal microecology reconstruction, nutritional supplements (NAD+, NMN, Ergothioneine), methylation, hyperbaric oxygen chambers, and hormone management!
Cell Biology Industry Sector: Covering the entire industry chain, including cell therapy, stem cells, exosomes, drug R&D, cellular instruments and consumables, laboratory equipment, and innovative biotechnology services and applications.
Featuring over 300 renowned hospitals and enterprises such as Tang Reproductive Hospital, Ciming Boao International Hospital, ShiGuanJia, Taotao Consulting, Tianjin Dongyi Technology, New Era Technology, Gebei Fertility, INCINTA, RD Clinic, IVF International Medical Center, Takanawa Clinic Group, AC International Medical, Nanxi Clinic, SinoCells, Vcanbio, InnoBrai, Shanghai Cell Therapy Group, Shandong Intestinal Microecology Technology, Biochip Shanghai, Aioxi Intelligent Technology, Xinrui Medical Anti-Aging Center, Wuku Electronic Technology, Anyuanhui, Ruiyi Biology, Zhongke Aiwei Biology, and Chengge Pharmaceutical Group. These exhibitors cover the core tracks of international healthcare, functional medicine, and the cell biology industry, comprehensively presenting full-chain solutions and industrial cooperation opportunities from "treatment" to "prevention," and from "life extension" to "age reversal."
4 Major Professional Forum Areas: The Core Zone for Ideological Collision
200+ Lectures to understand technology, clinical practice, policy, market, and cooperation opportunities:
International Assisted Reproductive Technology Forum
International Medical and Health Forum
International Chronic Disease Management Innovation Integration Forum
International Intestinal Microecology and Environment Reconstruction Forum
International Nutrient Conditioning Application Forum
Resisting the Power of Time: Longevity Technology Innovation and Health Protection Forum
International Cell Therapy and Medical Health Forum
The Innovation Wave of Cell Therapy: Technological Breakthroughs and Clinical Translation Forum
Frontier Forum on Regenerative Medicine: Clinical Translation and Industrial Innovation Driven by iPSC and Exosomes
Compliance Transformation and Value Reconstruction of Cell Application Enterprises under the 818/828 New Policies
Forum on Stem Cells: From Basic Research to Clinical Application
With such an expansive lineup of cutting-edge discussions spanning longevity, functional medicine, and reproductive health, we are excited to dive into the specifics of this intellectual feast. To kick things off, we are thrilled to unveil the detailed schedule for the first day of our highly anticipated cell-focused conferences.
Below is the agenda for Clinical Translation and Industrial Innovation Driven by iPSC and Exosomes taking place on April 24th. Please stay tuned to our official website and WeChat channels, as we will be releasing the full, detailed schedules for the remaining forums and subsequent exhibition days very soon!
April 24, Morning
Theme: Frontier Forum on Regenerative Medicine: Clinical Translation and Industrial Innovation Driven by iPSC and Exosomes
09:20-09:40
Organoid Printers and Embryosomes
Xu Tao
Professor, Tsinghua University
09:40-10:00
Natural Exosomes - Opening a New Era in Regenerative Medicine
Guo Jun
Founder, Nanjing Poyacell Biotechnology Co., Ltd.
10:00-10:20
The Latest Clinical Research Progress of Magical Cell Vesicles
Chi Xintong
BD Director, Beijing EchoBiotech Co., Ltd.
10:20-10:40
Advanced Regenerative Medicine Changing the Future
Taisei Kageyama
Yugokai Medical Corporation Takanawa Clinic Group
10:40-11:00
Multi-source Innovation and Industrial Breakthrough: Exosomes Driving New Changes in the Global Health Field
Ma Fang
R&D Director, Ehang (Suzhou) Biopharmaceutical Technology Co., Ltd.
11:00-11:20
Progress in Global Clinical Applications of Exosomes
Wang Zi'ang
O&M Manager, Hangzhou Exosome Biomaterial Technology Co., Ltd.
11:20-11:40
Regeneration, Anti-aging, and Stem Cells: From Scientific Research to Application
Gu Ying
CEO, BGI Cell
11:40-12:00
Breaking Limits to Release the Energy of PRP, Exosomes, and Cells
Yang Derong
Academic Director of Beijing Mingrui Technology Co., Ltd., Chief Researcher of the Institute of Medical Regenerative Medicine
April 24, Afternoon
Theme: Forum on the Compliance and Innovative Development of Cell Therapy under the "818/828" New Policies
14:00-14:20
InnoBrai's Dual-Track Strategy under the "818/828" New Policies
He Xiangfeng
Chief Medical Officer (CMO), Yingbairui (Hangzhou) Medical Research Co., Ltd.
14:20-14:40
Opportunities under "Document No. 818"
Bai Yongquan
Director of the Biomedical Industry Law Research Institute and Senior Partner, Huashang (Shanghai) Law Firm; Executive Director, Shenzhen Pingshan District Biomedical Industry Law Research Institute
14:40-15:0015:00-15:20
Beijing Health & Biotech Co., Ltd.
15:20-15:40
Lu Zhiping
Senior Director, Vcanbio Cell & Gene Engineering Corp., Ltd.
15:40-17:00
Roundtable Forum:
Compliance Transformation and Value Reconstruction of Cell Application Enterprises under the 818/828 New Policies - In-depth Interpretation of Strategic Layout under the Wave of Cell Therapy Compliance
• Gu Ying
• Lu Zhiping
• Miao Zhenwei
• Bai Yongquan
• BGI Cell
• Beijing Health & Biotech Co., Ltd.
• Vcanbro Cell & Gene Engineering Corp., Ltd.
• Yingbairui (Hangzhou) Medical Research Co., Ltd.
• Huashang (Shanghai) Law Firm
If you want to receive more conference agenda and details, please contact organizer: camelliachenchen@gmail.com.
